These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24811488)

  • 1. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.
    Wang LQ; Kwong YL; Wong KF; Kho CS; Jin DY; Tse E; Rosèn A; Chim CS
    J Transl Med; 2014 Feb; 12():52. PubMed ID: 24559316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer.
    Xie K; Liu J; Chen J; Dong J; Ma H; Liu Y; Hu Z
    Gene; 2014 Jun; 543(1):101-7. PubMed ID: 24704024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer.
    Tanaka N; Toyooka S; Soh J; Kubo T; Yamamoto H; Maki Y; Muraoka T; Shien K; Furukawa M; Ueno T; Asano H; Tsukuda K; Aoe K; Miyoshi S
    Lung Cancer; 2012 Apr; 76(1):32-8. PubMed ID: 22047961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma.
    Kubo T; Toyooka S; Tsukuda K; Sakaguchi M; Fukazawa T; Soh J; Asano H; Ueno T; Muraoka T; Yamamoto H; Nasu Y; Kishimoto T; Pass HI; Matsui H; Huh NH; Miyoshi S
    Clin Cancer Res; 2011 Aug; 17(15):4965-74. PubMed ID: 21673066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer.
    Toyota M; Suzuki H; Sasaki Y; Maruyama R; Imai K; Shinomura Y; Tokino T
    Cancer Res; 2008 Jun; 68(11):4123-32. PubMed ID: 18519671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.
    Zhang Q; Wang LQ; Wong KY; Li ZY; Chim CS
    J Clin Pathol; 2015 Jul; 68(7):557-61. PubMed ID: 25855800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of the miR-34a in hematological malignancies.
    Chim CS; Wong KY; Qi Y; Loong F; Lam WL; Wong LG; Jin DY; Costello JF; Liang R
    Carcinogenesis; 2010 Apr; 31(4):745-50. PubMed ID: 20118199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.
    Chim CS; Wan TS; Wong KY; Fung TK; Drexler HG; Wong KF
    J Transl Med; 2011 Nov; 9():197. PubMed ID: 22082000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of tumor suppressor miRNA genes: a lesson from the miR-34 family.
    Wong KY; Yu L; Chim CS
    Epigenomics; 2011 Feb; 3(1):83-92. PubMed ID: 22126155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome structure-based screening identified epigenetically silenced microRNA associated with invasiveness in non-small-cell lung cancer.
    Watanabe K; Emoto N; Hamano E; Sunohara M; Kawakami M; Kage H; Kitano K; Nakajima J; Goto A; Fukayama M; Nagase T; Yatomi Y; Ohishi N; Takai D
    Int J Cancer; 2012 Jun; 130(11):2580-90. PubMed ID: 21702040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K; Enokida H; Gotanda T; Kubo H; Nishiyama K; Kawahara M; Nakagawa M
    Biochem Biophys Res Commun; 2006 Jan; 339(3):790-6. PubMed ID: 16316628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias.
    Chim CS; Chan WW; Kwong YL
    J Clin Pathol; 2008 Jul; 61(7):844-7. PubMed ID: 18587015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas.
    Vogt M; Munding J; Grüner M; Liffers ST; Verdoodt B; Hauk J; Steinstraesser L; Tannapfel A; Hermeking H
    Virchows Arch; 2011 Mar; 458(3):313-22. PubMed ID: 21225432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
    Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
    J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect.
    Suzuki H; Yamamoto E; Nojima M; Kai M; Yamano HO; Yoshikawa K; Kimura T; Kudo T; Harada E; Sugai T; Takamaru H; Niinuma T; Maruyama R; Yamamoto H; Tokino T; Imai K; Toyota M; Shinomura Y
    Carcinogenesis; 2010 Dec; 31(12):2066-73. PubMed ID: 20924086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance.
    Rücker FG; Russ AC; Cocciardi S; Kett H; Schlenk RF; Botzenhardt U; Langer C; Krauter J; Fröhling S; Schlegelberger B; Ganser A; Lichter P; Zenz T; Döhner H; Döhner K; Bullinger L
    Leukemia; 2013 Feb; 27(2):353-61. PubMed ID: 22810507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia.
    Pigazzi M; Manara E; Baron E; Basso G
    Cancer Res; 2009 Mar; 69(6):2471-8. PubMed ID: 19258499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues].
    Zhang Q; He XJ; Ma LP; Li N; Yang J; Cheng YX; Cui H
    Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):885-90. PubMed ID: 22340095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.